People struggling with many addictions, ranging from opioids to gambling, are reporting similar experiences in clinics, on ...

Researchers at Washington University School of Medicine in St. Louis have shown in a new study that GLP-1 medications may be ...

A nonfatal opioid overdose is often treated as a near miss. But clinically, it is one of the strongest predictors of future harm—and one of the few moments when patients are actively engaged with the ...

The effect was seen across a wide variety of addictive and habit-forming substances, including cocaine, opioids, alcohol, ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

GLP-1 drugs like Ozempic have long helped people eat less — now, they’re showing promise in helping people crave less. A new analysis of records from over 600,000 diabetic veterans found that GLP-1 ...

Prescription weight loss drugs have been lauded as the miracle drug for treating diabetes and obesity, but new research suggests that these drugs, known as glucagon-like peptide-1 (GLP-1) ...

A large study found that people taking GLP-1 drugs like Ozempic for diabetes were less likely to be diagnosed with substance use disorder.

GLP-1 medications may quiet the brain signals behind addiction, reducing substance use disorders and overdose risk across ...

Lev Facher covers the U.S. addiction and overdose crisis. Black and Hispanic people are “significantly less likely” to receive two medications used to treat opioid addiction, according to a new study.

A study in The BMJ found GLP-1 drugs used for diabetes and obesity may also curb addiction by reducing cravings. Researchers ...

Researchers at Washington University School of Medicine in St. Louis show in a new study that GLP-1 medications may be ...